Susan has more than 25 years of global, cross-functional experience in the consumer healthcare industry and has worked across many therapeutic categories for industry leaders such as Merck/Schering-Plough, Pfizer/Warner-Lambert and SmithKline Beecham.
In 2011, Susan founded a boutique consulting firm providing strategy, business development and marketing services in the consumer healthcare space. Susan B. Levy Consulting, LLC works with its clients on a brand, category or portfolio basis to develop and implement strategies for growth, including acquisitions, technology search, in-licensing of new technologies, Rx to OTC switch, and effective and efficient marketing programs. Susan has consulted, presented and authored articles on Rx to OTC switches.
Most recently Senior Director, Strategy Development for Merck & Co., Inc., Susan worked directly with Merck’s CEO and his leadership team to develop breakthough strategies that would transform Merck from a global pharmaceutical company to a global healthcare company. Previously, Susan was Senior Director, Global New Ventures and Strategic Commercial Development for Schering-Plough Consumer Healthcare. In this role she was responsible for pursuing profitable external growth opportunities, including new technologies, Rx to OTC switches, acquisitions and alliances for the $1.9B+ Consumer HealthCare division of Schering-Plough. Susan personally managed more than six development and exploratory phase switch programs with a total value exceeding $800MM.
Prior to joining Schering-Plough in 2006, Susan worked at Pfizer Consumer Healthcare. In her final role there, she established a business model to manage the division’s first Rx drug, Nicotrol, and developed a strategy to expand the Rx platform within the consumer business. From 2000 to 2002, Susan managed the Visine brand on a global basis, delivering double-digit top and bottom line growth; she also launched the brand in Brazil. Susan was a member of both the Switch Selection Team and Switch Steering Team.
Susan began her career in R&D at Unilever before joining Beecham Products in New Product Development (later SmithKline Beecham). As Manager, Portfolio Analysis, Susan provided strategic business support for the Gastro-Intestinal, Respiratory Tract, Analgesic and Diagnostic Categories and New Business Development, including portfolio evaluation and project prioritization of Rx to OTC switch opportunities.
Susan received her B.A. in chemistry from Cornell University and attended NYU’s Stern School of Business for her MBA.